Immuneering Corp
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Immuneering Corp
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
/ 
Frequently asked questions
To buy Immuneering Corp stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Immuneering Corp by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Immuneering Corp is IMRX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Immuneering Corp has its primary listing on NASDAQ. You can trade Immuneering Corp with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Immuneering Corp is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Immuneering Corp as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Immuneering Corp.